Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

Social Media Reacts to Eli Lilly’s Price Reduction of Insulin

| Stephanie Vine | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?

Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Business & Regulation Business Practice

A Roadmap to Greener Pharma Logistics

| Julius Graf von Pfeil, Kees Schmidt | 10 min read

How to make the art of pharmaceutical logistics more sustainable.

Business & Regulation Business Practice

Focusing on Sustainability

Download our eBook to find out how the industry is trying to be more sustainable.

Business & Regulation Trends & Forecasts

Weathering the Storm: Cell and Gene’s Economic Downturn

| James Wilson, Anshul Mangal | 5 min read

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Vine | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Business & Regulation Business Practice

A Contentious Issue

| Stephanie Vine | 4 min read

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Business & Regulation Business Practice

Biotechs in the Baltic

| Angus Stewart | 12 min read

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Business & Regulation Business Practice

It’s a Material World…

| Angus Stewart | 2 min read

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Business & Regulation Business Practice

Diversity Matters

| Stephanie Vine | 4 min read

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register